“ECG manifestations of meglumine antimoniate in treatment of cutaneous leishmaniasis”, J Pak Assoc Dermatol, vol. 30, no. 3, pp. 382–387, Oct. 2020, doi: 10.66344/jpad.v30i3.1568.